Over 200 years after William Withering wrote the classic monograph,
An Account of the Foxglove and Some of Its Medicinal Uses,
1 the indications for and optimal dosing of digitalis glycosides (primarily prescribed as digoxin) continue to be debated. Convincing evidence regarding the purported benefits of digoxin was unavailable until the Digitalis Investigation Group (DIG) trial, published in 1997.
2 This study was approved by the institutional review board at each participating center.